# Sofosbuvir + Velpatasvir + Voxilaprevir

## Vosevi 400/100/100mg

| TAH Drug Code      | [OVOS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OVOS)                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis (Child-Pugh class A) who meet at least one of the following criteria: ‧ Genotype 1， 2， 3， 4， 5， or 6 and have previously received an HCV regimen containing an NS5A inhibitor. ‧ Genotype 1a or 3 and have previously received an HCV regimen containing sofosbuvir but without an NS5A inhibitor. |
| Dosing             | One tablet contains sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100mg. 1 tablet once daily with meal for 12 weeks.                                                                                                                                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | VOSEVI is contraindicated for use with rifampin.                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Common Gastrointestinal: Diarrhea (13% to 14% )， Nausea Neurologic: Headache (21% to 23% ) Other: Fatigue (17% to 19% ) Serious Cardiovascular: Bradyarrhythmia， Cardiac arrest Hepatic: Decreased liver function， Liver failure， Reactivation of hepatitis B viral hepatitis                                                                                                                                         |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/sofosbuvir-velpatasvir-and-voxilaprevir-drug-information)                                                                                                                                                                                                                                                                                                                    |

